Упрощенная HTML-версия
90. Furukawa F. A cyclooxygenase-2 inhibitor, nimesulide, inhibits postinitiation phase
of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters / F. Furukawa F,
A. Nishikawa, I.S. Lee et al. // Int. J. Cancer. - 2003. - Vol. 104, № 3. - Р. 269-273.
91. Gastric and duodenal mucosal blood flow in patients receiving non-steroidal anti-
inflammatory drugs— influence of age, smoking, ulceration and Helicobacter pylori / A.S. Taha, W.
Angerson, I. Nakshabendi et al. // Aliment. Pharmacol. Ther. – 1993. – Vol.7. – P. 41–45.
92. Gastric antiulcer activity of Syngonanthus arthrotrichus SILVEIRA / L.M. Batista,
A.B. de Almeida, L. de Pietro Magri et al. // Biol. Pharm. Bull. – 2004. – Vol.27,№3. – Р.328-332.
93. Gastric microcirculation as target of gastroprotective action of glucocorticoid
hormones in rats with desensitization of capsaicin-sensitive sensory neurons / P. Bobryshev, T.
Podvigina, N. Maltcev, L. Filaretova // Inflammopharmacology. – 2006. – Vol. 14, №5-6. – Р. 236-
242.
94. Gastric mucosal blood flow changes in Helicobacter pylori infection and NSAID-
induced gastric injury / J.I. Elizalde, A. Mendez, J. Gomez et al. // Helicobacter. – 2003. – Vol.8,
№2. – Р.124-131.
95. Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide
donator: proof of concept study in humans / A. Bobrzynski, P.C. Konturek, S.J. Konturek et al. //
Gut. – 2003. – Vol. 52, №11. – Р. 1537-1542.
96. Gastroprotection by vitamin C—a heme oxygenase-1-dependent mechanism? / J.C.
Becker, N. Grosser, P. Boknik et al. // Biochem. Biophys. Res. Commun. – 2003. – Vol.312,№2. –
Р. 507-152.
97. Giannattasio A. Steroid therapy for a case of severe drug-induced cholestasis / А.
Giannattasio M., D’Ambrosi, M. Volpicelli et al. //Ann. Pharmacother. – 2006. Vol. 40. № 6. P.
1196-1199.
98. Gitlin N. Response to: Appropriate choice of proton pump inhibitor therapy in the
prevention and management of NSAID-related gastrointestinal damage / N. Gitlin, A.L. Weaver //
Int. J. Clin. Pract. – 2006. – Vol. 60, №5. – Р. 609-610.
99. Goldstein J.L. Challenges in managing NSAID-associated gastrointestinal tract injury
/ J.L. Goldstein // Digestion. – 2004. - Suppl 1. – P. 25-33.
100.Graham D.Y. Visible small-intestinal mucosal injury in chronic NSAID users / D.Y.
Graham, A.R. Opekun, F.F. Willingham et al. // Clin. Gastroenterol. Hepatol. – 2005. Vol. 3, № 1. -
Р. 55-59.
101.Guarana (Paullinia cupana Mart.) offers protection against gastric lesions induced by
ethanol and indomethacin in rats / A.R. Campos, A.I. Barros, F.A. Santos et al. // Phytother. Res. –
2003. – Vol.17,№10. – Р. 1199-1202.
102.Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and
bleeding of peptic ulcers / K.C. Lai, C.S. Lau, W.Y.Ip et al. // Med. Sci. Monit. – 2005. –Vol.
11,№3. – Р.132-135.
103.Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and
bleeding of peptic ulcers / A. Bobrzynski, P.C. Konturek, S.J. Konturek et al. // Med. Sci. Monit. –
2005. – Vol.11, №3. – Р. 132-135.
104.Helicobacter pylori infection and abnormalities of acid secretion in patients with
duodenal ulcer disease / E.M. el-Omar, I.D. Penman, J.E. Ardill et al. // Gastroenterology. – 1995. –
Vol.109. – P. 681–691.
105.Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for
bleeding duodenal ulcers in NSAID users / S. Santolaria, A. Lanas, R. Benito et al. // Aliment.
Pharmacol. Ther. – 1999. – Vol.13. – P. 1511–1518.